A cocktail of synthetic antibodies reduces deaths among severe COVID patients who are unable to mount a strong immune response, results from a major clinical trial […]
As cases tumble and states reopen, the potential final stage in the U.S. campaign to vanquish COVID-19 is turning into a slog, with a worrisome variant […]
New study results indicate that different comorbid conditions affecting individuals diagnosed with COVID-19 may impact how long they continue to receive positive SARS-CoV-2 polymerase chain reaction […]